Direct to Patient Drug Delivery
Direct to Patient Drug Delivery
Direct-to-Patient (DTP) drug delivery, allows investigational drugs to be sent directly to trial participants. This design element is increasingly used in clinical trials due to its flexibility and cost optimisation benefits.
Benefits of DTP
- Increased Pool of Trial Participants: DTP expands access to a broader patient population.
- Enhanced Patient Compliance: Direct delivery encourages adherence to treatment protocols.
- Reduced Dropouts: Convenience and timely delivery minimize patient attrition.
Our Commitment
At QCS, we recognize that DTP represents the future of clinical trials. Our experienced team ensures that drugs reach participants promptly while maintaining patient confidentiality throughout the process.
Full Support for Successful DTP Trials
We offer comprehensive support for successful DTP trials, including:
- IMP Receipt from Manufacturer and Sponsor
- Pharmacy Hub and Storage
- Release and Dispensing for Participants
- Recorded Delivery and Receipt
- Error-Free Drug Accountability
- Inventory Control
- Return of Unused IMPs
- Provision of NIMPs (Non-Investigational Medicinal Products)
- Disposal of Unused Investigational Products
- Coordination with Study Principal Investigator, CRA and Study Nurse
To discuss your Direct-to-Patient Drug requirements, please feel free to contact our dedicated team today. We’re here to support your research endeavours. 🌟